$WOK

HRT FINANCIAL LP sold $168K of WOK

HRT FINANCIAL LP sold 2,904,567 shares of WORK Medical Technology Group LTD (WOK) at $0.06 ($0.17M total) on 2026-06-16.

Original reporting
SEC EDGAR · HRT FINANCIAL LP
Published Jun 17, 2026, 8:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 17, 2026, 8:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$WOK
Bearish
medium confidence
Mentioned
$WOK
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$WOKBearishLow
01

Why it matters

A 10% owner executed an open-market sale totaling about $168.5K at $0.0580/share; this can influence short-term sentiment but is not a company performance or guidance update.

02

Market read

Traders may monitor WOK for sentiment/flow effects from insider selling, but the disclosure alone is unlikely to drive a sustained repricing without additional fundamentals.

03

What to watch

The filing doesn’t disclose reasons for selling, whether proceeds fund other investments, or whether other insiders are buying; without accompanying operational updates, price impact may fade.

Relevance 4/10Novelty 8/10Timing: SEC Form 4 filed 2026-06-17 (after-hours/next session impact)

Background

The article is an SEC Form 4 insider transaction disclosure for WORK Medical Technology Group (WOK).

Company-level read

Ticker impact

$WOKBearishMedium confidence
Context

HRT Financial LP, a 10% owner, filed an open-market sale of 2,904,567 WORK Medical Technology Group shares at $0.0580 each.

Expected impact

Near-term downside bias or volatility around the filing; magnitude likely limited without additional company news.

Evidence & confidence

Form 4 shows a large share sale and no 10b5-1 plan, which can be read as discretionary selling, but insider sales often have non-informational motives and the filing alone doesn’t change fundamentals.

Market effects

Limited sector read-through; this is a single-company ownership transaction.

No clear regional spillover indicated by the filing.

Minimal global relevance beyond the issuer’s shareholder base.

Counterpoint

The sale may be routine liquidity/portfolio rebalancing; absence of a stated 10b5-1 plan doesn’t necessarily imply negative information.

Key entities

  • WORK Medical Technology Group LTD

    Subject of the Form 4 insider transaction; 10% owner sold shares via open-market sale.

  • HRT Financial LP

    Reporter on the Form 4; sold 2,904,567 shares and reported holdings after transaction of 391,456 shares.

Related articles